4,4-Dimethyl-1,3-oxazolidin-2-one

Suppliers

Names

[ CAS No. ]:
26654-39-7

[ Name ]:
4,4-Dimethyl-1,3-oxazolidin-2-one

[Synonym ]:
4,4-Dimethyl-oxazolidin-2-one
4,4-Dimethyl-1,3-oxazolidin-2-one
2-Oxazolidinone, 4,4-dimethyl-

Chemical & Physical Properties

[ Density]:
1.0±0.1 g/cm3

[ Boiling Point ]:
272.2±7.0 °C at 760 mmHg

[ Molecular Formula ]:
C5H9NO2

[ Molecular Weight ]:
115.131

[ Flash Point ]:
118.4±18.2 °C

[ Exact Mass ]:
115.063332

[ PSA ]:
38.33000

[ LogP ]:
0.70

[ Vapour Pressure ]:
0.0±0.6 mmHg at 25°C

[ Index of Refraction ]:
1.424

[ Storage condition ]:
2-8°C

MSDS

Click to get detail MSDS

Safety Information

[ HS Code ]:
2934999090

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

  • Carbamic acid, 2-methylpropyl ester
  • carbon monoxide
  • 2-Amino-2-methyl-1-propanol
  • Ethyl carbonate
  • Ethyl chloroformate
  • 2-Oxazolidinethione,4,4-dimethyl-
  • 2-methylpropyl N-hydroxycarbamate
  • cis-1,2-Cyclohexanedimethyl bis[N-(2-hydroxy-1,1-dimethylethyl)carbamate]
  • 1-(2-hydroxy-1,1-dimethylethyl)urea
  • Ethylene carbonate

DownStream

  • 4,4-dimethyl-3-prop-2-enoyl-1,3-oxazolidin-2-one
  • 3-(2-Bromopropanoyl)-4,4-dimethyl-1,3-oxazolidin-2-one
  • (4,4-dimethyl-2-oxo-1,3-oxazolidin-3-yl)methylphosphonic acid
  • 3-BROMO-4,4-DIMETHYL-2-OXAZOLIDINONE

Customs

[ HS Code ]: 2934999090

[ Summary ]:
2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Related Compounds

  • 3-bromo-4,4-dimethyl-1,3-oxazolidin-2-one
  • 3-chloro-4,4-dimethyl-1,3-oxazolidin-2-one
  • 5-Ethynyl-4,4-dimethyl-1,3-oxazolidin-2-one
  • 3-acryloyl-4,4-dimethyl-1,3-oxazolidin-2-one
  • 3-(2-Bromopropanoyl)-4,4-dimethyl-1,3-oxazolidin-2-one
  • 4,4-Dimethyl-3-(4-piperidinyl)-1,3-oxazolidin-2-one
  • Bottromycamide A1
  • (2S,3R,4S,5S,6R)-2-[(2S)-2-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-6-methylhept-4-en-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
  • (52S)-Ciguatoxin
  • 1-Trinonacontene
  • Zinc norfloxacin
  • [11,37-Diformyl-4,5,5,14,20,21,22,25,26,30,31,32,44,45,46,49,56-heptadecahydroxy-6,9,17,35,41,53,60-heptaoxo-38-(3,4,5-trihydroxybenzoyl)oxy-2,10,16,28,36,40,54,57,61-nonaoxadecacyclo[37.11.6.413,27.14,50.03,8.018,23.029,34.042,47.048,52.024,59]henhexaconta-1(50),7,18,20,22,24,26,29,31,33,42,44,46,48,51,58-hexadecaen-12-yl] 3,4,5-trihydroxybenzoate
  • 1-Dononacontene
  • (2S,3S,4S,5R,6R)-6-[[(3S,4aR,6aR,6bS,8aR,10S,11S,12R,12aS,14aR,14bR)-8a-carboxy-10-hydroxy-4,4,6a,6b,11,12,14b-heptamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picen-3-yl]oxy]-3,4-dihydroxy-5-[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxane-2-carboxylic acid
  • Portulaxanthin
  • (2R,3R,4S,5S,6R)-2-[(2R)-4-[(6R,7S,9S,13S,16S,18R)-16-[(2R,3R,4S,5R,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-hydroxy-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosan-6-yl]-2-methylbutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.